Toolbox
- size +

FDA turns down application for combo allergy drug

(AP) -- The Food and Drug Administration has turned down an application by two drugmakers to produce an allergy drug combining the active ingredients of their popular Claritin and Singulair tablets.



Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .




» Next Article in Medicine & Health - Medications: Baxter may stay out of Heparin business

would you recommend this story?

 

User Rating

1 vote(s) so far; rank not shown
  • not at all
  • 1
  • 2
  • 3
  • 4
  • 5
  • highly

Leave a Comment or

 
Physorg Account Physorg Account PhysOrg Forum PhysOrg Forum ideo Video Goto Editorials Editorials Free Magazines Free Magazines Free white papers Free White Papers Newsletter Newsletter

News Archive

Relevant Stories